The hallmark of allergic diseases is the infiltration and accumulation of Th2 cells at the sites of inflammation; however the molecular mechanisms governing tolerance induction in Th2 cells and their relation to allergic responses are poorly understood. Thus, today it is becoming clear that understanding the Th2 cell biology and ways to control their function may prove to be invaluable for the treatment of allergic inflammation. Recently, we as well as others have demonstrated the role of E3 ubiquitin ligases such as Grail and Itch in induction of Th2 cell tolerance. Cullin4A (Cul4A) belongs to the evolutionally conserved E3 ubiquitin ligase family and has been suggested to be involved in hematopoietic cell activation and in chromatin regulation; however, the role of Cul4A in T lymphocytes has not been addressed yet. Interestingly, expression of Cul4A was upregulated in tolerant T cells. Moreover, Cul4A knockout CD4+ T cells activated in vitro under tolerogenic conditions exhibited an enhanced level of proliferation and IL-2 production compared to wild-type cells, suggesting an important role of Cul4A in regulation of T cell tolerance. Strikingly, we found that Cul4A deficient Th2 and Treg cells expressed higher levels of Th2 cytokines, which correlates with increased levels of IgG1 and IgE in the sera of Cul4A deficient mice, indicating the selective role of Cul4A in controlling Th2 programming and Th2 mediated inflammation. We also detected reduced Cul4A expression in CD4+ T cells from asthmatic patients compared to CD4+ T cells from healthy donors, further indicating that Cul4A potentially regulates the tolerogenic process in pro-allergic Th2 cells. In addition, shRNA knockdown of Cul4A in human CD4+ T cells resulted in upregulated expression of Th2-specific cytokines. Based on these findings, we hypothesize that regulation of Th2 cell function by Cul4A may be an important checkpoint in airway tolerance induction, which is crucial to prevent development of allergic diseases.
In Aim 1, we propose to determine the molecular mechanisms whereby Cul4A controls T cell tolerance by utilizing gene knockdown approaches and in vitro and in vivo Th2 tolerance induction models.
In Aim2, we will determine the role of Cul4A in Th2 cell programming and its underlying mechanisms as well. We will employ cutting edge technologies, including two-hybrid screening and microarray analysis of gene expression, to identify the exact target(s) of Cul4A to determine its function in Th2 development. In addition, we will assess the cellular mechanisms whereby Cul4A controls Th2 type mediated airway inflammation.
In Aim3, we will determine the mechanism by which Cul4A regulates Tregs function, particularly the acquisition of Th2-like properties. The physiological significance of this finding will be analyzed in three different in vivo models. The proposed research will provide new significant insight into characterization of molecular mechanisms underlying Cul4A-mediated tolerogenic process in Th2 cells that may potentially have therapeutic implications for allergic diseases.

Public Health Relevance

Of the T helper (Th) subsets, the Th2 cells are the major players in allergic airway inflammation; however, the mechanisms that control Th2-mediated inflammation are poorly understood. The central goal of this project is to understand the functions of the E3 ubiquitin ligase Cul4A in tolerance induction in Th2 cells and its relation to allergic responses. Our results will provide novel insight into the molecular mechanisms explaining the generation of peripheral Th2 cell tolerance, which will have implications in the prevention and treatment of allergic diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI125269-01A1
Application #
9429256
Study Section
Transplantation, Tolerance, and Tumor Immunology Study Section (TTT)
Program Officer
Davidson, Wendy F
Project Start
2017-03-13
Project End
2019-02-28
Budget Start
2017-03-13
Budget End
2019-02-28
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Microbiology/Immun/Virology
Type
Hospitals
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Khosravi, Nasim; Caetano, Mauricio S; Cumpian, Amber M et al. (2018) IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties. Cancer Immunol Res 6:788-797
Na, Hyeongjin; Lim, Hoyong; Choi, Garam et al. (2018) Concomitant suppression of TH2 and TH17 cell responses in allergic asthma by targeting retinoic acid receptor-related orphan receptor ?t. J Allergy Clin Immunol 141:2061-2073.e5
Haymaker, Cara L; Hailemichael, Yared; Yang, Yi et al. (2017) In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model. J Vis Exp :